Vivian A Fonseca
Overview
Explore the profile of Vivian A Fonseca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
5172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li P, Ali M, Narayan K, Umpierrez G, Fonseca V, Shi L, et al.
Diabetes Care
. 2025 Jan;
PMID: 39841556
No abstract available.
2.
Guo J, Tang H, Shao H, Lu Y, Shi L, Fonseca V, et al.
Diabetes Obes Metab
. 2024 Sep;
26(12):5727-5736.
PMID: 39256938
Importance: Diabetes increases the risk of Parkinson disease (PD). Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a new glucose-lowering therapeutic class, have shown neuroprotective effects in mechanistic studies. However, the association between...
3.
Lamas G, Anstrom K, Navas-Acien A, Boineau R, Nemeth H, Huang Z, et al.
JAMA
. 2024 Aug;
332(10):794-803.
PMID: 39141382
Importance: In 2013, the Trial to Assess Chelation Therapy (TACT) reported that edetate disodium (EDTA)-based chelation significantly reduced cardiovascular disease (CVD) events by 18% in 1708 patients with a prior...
4.
Zhang Y, Parajuli K, Fonseca V, Wu H
Regen Med
. 2024 Aug;
19(5):239-246.
PMID: 39118533
Type II diabetes (T2D) stems from insulin resistance, with β-cell dysfunction as a hallmark in its progression. Studies reveal that β cells undergo apoptosis or dedifferentiation during T2D development. The...
5.
Sex differences in circulating metabolites across glycemic status and risk of coronary heart disease
Yoshida Y, Li D, Li X, Fonseca V, Qi L, Mauvais-Jarvis F
medRxiv
. 2024 Aug;
PMID: 39108525
Background: Women with type 2 diabetes (T2D) have a 50% excess risk of coronary heart disease (CHD) than men with T2D. We compared circulating metabolites and their associations with CHD...
6.
Horswell R, Chu S, Stone A, Fort D, Uwaifo G, Fonseca V, et al.
BMJ Open Diabetes Res Care
. 2024 Aug;
12(4).
PMID: 39107077
Introduction: The objective of this study was to determine the burden of influenza disease in patients with or without diabetes in a population of American adults to understand the benefits...
7.
DeFronzo R, Auchus R, Bancos I, Blonde L, Busch R, Buse J, et al.
BMJ Open
. 2024 Jul;
14(7):e081121.
PMID: 39013654
Introduction: Even with recent treatment advances, type 2 diabetes (T2D) remains poorly controlled for many patients, despite the best efforts to adhere to therapies and lifestyle modifications. Although estimates vary,...
8.
Tang H, Lu Y, Donahoo W, Shao H, Shi L, Fonseca V, et al.
Ann Intern Med
. 2024 Jul;
177(8):1004-1015.
PMID: 39008852
Background: A major concern has recently emerged about a potential link between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and increased risk for suicidal ideation and behaviors based on International Classification...
9.
Li P, Kianmehr H, Guan D, Kulshreshtha A, Narayan K, Ali M, et al.
Diabetes Obes Metab
. 2024 Jul;
26(9):3958-3968.
PMID: 38962812
Aim: Dysglycaemia accelerates cognitive decline. Intensive glucose control may help delay or prevent cognitive function decline (CFD). We aimed to determine how patient characteristics influence the effect of intensive glucose...
10.
Nguyen H, Ardeshir A, Fonseca V, Kim W
Clin Chim Acta
. 2024 Jun;
561():119819.
PMID: 38901629
Metabolic syndrome (MetS) represents a significant public health concern due to its association with an increased risk of cardiovascular disease, type 2 diabetes, and other serious health conditions. Despite extensive...